NEW YORK (GenomeWeb News) - Rosetta Genomics said today it has licensed PCR technology from Roche Molecular Diagnostics for use in its microRNA-based diagnostic tests.
The company plans to use the PCR technology in its efforts to identify microRNA biomarkers in several different sample types and body fluids.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.